R2101221 |
BI-1467335 HCl |
BI-1467335, also known as PXS-4728A, is a SSAO/VAP inhibitor potentially for the
|
R2101222 |
Vicriviroc Malate(maleate) |
Vicriviroc maleate(Sch-417690) is a piperazine-based CCR5 receptor antagonist wi
|
R2101223 |
Givinostat(free base) |
Givinostat or gavinostat, aslo known as ITF2357, is a potent and orally active h
|
R2101224 |
WYE-687 |
WYE-687 is an ATP-competitive and selective inhibitor of mTOR with IC50 of 7 nM;
|
R2101225 |
TAK-220 |
TAK-220 is a selective and orally bioavailable CCR5 antagonist (IC50s: 3.5 nM an
|
R2101226 |
SEL120 |
SEL120-34A is a selective, orally available, and ATP-competitive CDK8 inhibitor
|
R2101227 |
Olinciguat |
Olinciguat is an oral guanylate cyclase (sGC) stimulator. It also has concentrat
|
R2101228 |
Vicriviroc Malate |
Vicriviroc has a higher binding affinity to CCR5 as opposed to SCH-C in competit
|
R2101229 |
STING agonist-4 |
STING agonist-4 is an agonist of stimulator of Interferon Genes (STING) receptor
|
R2101230 |
WAY-600 |
WAY-600 is a potent, ATP-competitive and selective inhibitor of mTOR with IC50 o
|
R2101231 |
BGT226 maleate (NVP-BGT226 maleate) |
BGT226 (NVP-BGT226) is a class I PI3K/mTOR inhibitor for PI3Kα/β/γ (IC50: 4/63/3
|
R2101232 |
Arginase inhibitor 1 |
Arginase inhibitor 1 is a potent inhibitor of human arginases I and II (IC50s: 2
|
R2101233 |
acivicin;AT-125; U-42126 |
Acivicin (AT-125), a natural product produced by Streptomyces sviceus, is a γ−gl
|
R2101234 |
Cenicriviroc(mesylate) |
Cenicriviroc Mesylate is a dual CCR2/CCR5 antagonist, also inhibits both HIV-1 a
|
R2101235 |
AZD4573 |
AZD4573 is an effective and selective CDK9 inhibitor (IC50: <4 nM). It enable
|
R2101236 |
WYE-354 |
WYE-354(IC50=5 nM) is an effective, selective and ATP-competitive mTOR inhibitor
|
R2101237 |
ML-SA1 |
activator of TRPML channels.
|
R2101238 |
Fezolinetant |
Fezolinetant is an antagonist of the neurokinin 3 receptor (NK3R). It is used fo
|
R2101239 |
AZD-4320 |
AZD4320 is an inhibitor of BH3-mimicking dual BCL2/BCLxL. For KPUM-MS3, KPUM-UH1
|
R2101240 |
RTA 405 |
CDDO-EA is an activator of NF-E2 related factor 2/antioxidant response element (
|
R2101241 |
BDTX-189 |
BDTX-189 is an orally bioavailable, irreversible, selective, small-molecule inhi
|
R2101242 |
E3 Ligase Ligand-Linker Conjugates 2 |
E3 Ligase Ligand-Linker Conjugates 2 is a synthesized E3 ligase ligand-linker co
|
R2101243 |
E3 ligase Ligand-Linker Conjugates 28 |
(S,R,S)-AHPC-C4-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conju
|
R2101244 |
E3 Ligase Ligand-Linker Conjugates 20 |
Thalidomide-O-amido-C8-NH2 (Cereblon Ligand-Linker Conjugates 2), a synthesized
|
R2101245 |
E3 ligase Ligand-Linker Conjugates 7 |
(S,R,S)-AHPC-PEG4-NH2 hydrochloride is a synthesized E3 ligase ligand-linker con
|